Combined Heart and Liver Transplantation: The Asan Medical Center Experience.
10.4285/jkstn.2017.31.2.91
- Author:
Hyo In CHOI
1
;
Tae Jin YUN
;
Sung Ho JUNG
;
Jae Won LEE
;
Gi Won SONG
;
Sung Gyu LEE
;
Kyung Mo KIM
;
Jae Joong KIM
Author Information
1. Division of Cardiology, Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea. jjkim@amc.seoul.kr
- Publication Type:Case Report
- Keywords:
Heart transplantation;
Liver transplantation;
Multi-organ transplant;
End-stage heart disease
- MeSH:
Biopsy;
Brain Edema;
Chungcheongnam-do*;
Heart Transplantation;
Heart*;
Humans;
Hyperammonemia;
Korea;
Liver Diseases;
Liver Failure;
Liver Transplantation*;
Liver*;
Optimism;
Transplants
- From:The Journal of the Korean Society for Transplantation
2017;31(2):91-98
- CountryRepublic of Korea
- Language:English
-
Abstract:
Combined heart-liver transplantation (CHLT) is an increasingly accepted treatment for select patients with advanced heart and liver disease. However, CHLT are infrequently performed, despite growing optimism about their effectiveness. Here, we report Asan Medical Center experience with CHLT in three patients presenting with advanced heart and liver failure. One patient died of brain swelling because of intractable hyperammonemia on postoperative day 9. The two other patients were still alive at 53 and 9 months postsurgery. None of these patients required readmission for cardiac or hepatic graft dysfunction and no rejection episodes were detected on routine cardiac biopsies. This is the first report of CHLT cases from Korea.
